July 17, 2023 /

Research Row Breakout Session: Approved or on the Horizon – PPMD 2023 Annual Conference

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Research Row: Approved or on the Horizon

Join us as we discuss Approved Therapies and those on the Horizon of approval.

  • Santhera Pharmaceuticals (Vamorolone)
  • Italfarmaco ( Givinostat)
  • PTC Pharmaceuticals (Ataluren, Emflaza)
  • Sarepta Therapeutics (Amondys45, Exondys 51, Vyondys53)
  • NS Pharma (Viltepso)
2023 PPMD Annual Conference,
Conferences & Meetings

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo